CVE-2022-30297

Name: CVE-2022-30297
Creator: NVD / NIST
Published: 2022-11-11T16:15:14.49+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

HIGHCVSS 7.8/10EPSS 0.17%

Last modified Jun 17, 2026

CVE-2022-30297 is a high-severity vulnerability rated 7.8/10 on the CVSS scale. Cross-site scripting in the Intel(R) EMA software before version 1.8.0 may allow a privileged user to potentially enable escalation of privilege via local access.. EPSS estimates a 0.17% chance of exploitation in the next 30 days.

Description

Cross-site scripting in the Intel(R) EMA software before version 1.8.0 may allow a privileged user to potentially enable escalation of privilege via local access.

Metrics

CVSS 3.1

7.8/10

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

EPSS Probability

0.17%

6.5th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

Vendor	Product	Versions
Intel	Endpoint Management Assistant	< 1.8.0

References

https://www.intel.com/content/www/us/en/security-center/advisory/intel-sa-00716.htmlVendor Advisory
https://www.intel.com/content/www/us/en/security-center/advisory/intel-sa-00716.htmlVendor Advisory

Timeline

Published: Nov 11, 2022
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2022-30297?

Cross-site scripting in the Intel(R) EMA software before version 1.8.0 may allow a privileged user to potentially enable escalation of privilege via local access.

How severe is CVE-2022-30297?

CVE-2022-30297 has a CVSS score of 7.8/10 (HIGH severity). The EPSS model estimates a 0.17% probability of exploitation in the next 30 days.

How do I fix CVE-2022-30297?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2022-30297?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST